Trial in progress

Can a blood test decide who needs treatment after surgery?

MRD2START · Asan Medical Center · 172 people planned · Registered completion June 2031

Not yet openRegistered completion June 2031

What is being tested

After surgery, a blood test looks for leftover tumor DNA. Tislelizumab is given based on the result.

Why it matters

If it works, people with no detectable tumor DNA could skip extra treatment.

ClinicalTrials.gov record ↗ ← Back to the outlook

Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.